Dr. Alison A. Fischer, MD

Dr. Fischer practices at Southside Dermatology in Tulsa, Oklahoma.

Dr. Fischer's NPI, 1225266307, was assigned on June 26, 2009. Dr. Fischer graduated from OU College of Medicine in 2009. Dr. Fischer holds Oklahoma license 27303.

Dr. Fischer's primary practice is Southside Dermatology, at 6966 S Utica E Ave, Tulsa, OK 74136 in Tulsa County. The practice phone is (918) 760-0700.

Dr. Fischer's primary practice is Southside Dermatology in Tulsa, Oklahoma. The medical group on file is Southside Dermatology and Skin Cancer Surgery. Dmand AI also links Dr. Fischer to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fischer practices. Vendor and product names are available with a free account.

Dermatology is Dr. Fischer's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Fischer is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Fischer's licenses on file in 2 states: Oklahoma and Rhode Island.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, corns and calluses, facial skin infection and hives among the conditions Dr. Fischer treats.

CMS data shows 6,483 Medicare services from Dr. Fischer across 35 procedure codes in 2024, for 866 Medicare patients. Medicare paid $599,862 for them. Every service was in an office.

CMS counts 866 Medicare patients who saw Dr. Fischer in 2024. The largest group is 65 to 74, with 433 patients. 74% of them have high blood pressure, and 70% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fischer's median patient age at 66, with 56% women.

In 2024, Dr. Fischer wrote 782 Medicare Part D claims for 317 patients. 91% of them were for generic drugs. CMS names the drug for 588 of them, across 20 drugs with 11 or more claims each, at $265,573 in total drug cost. In 2023, CMS named 726 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Fischer for performance year 2024, reported as part of a group. Dr. Fischer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 97 procedures of melanoma (skin cancer) excision by Dr. Fischer, more than 93% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Fischer, published from 2017 to 2023. Dr. Fischer has published most often in Cutis. Dr. Fischer's most frequent co-authors are Andrew Blauvelt, MD, Jack Cossman, MD and Dean David George, MD.

Dmand AI links Dr. Fischer to 3 clinical trials, 3 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Dermatitis, Atopic, Skin Diseases, Eczematous and Eczema. AbbVie sponsors the most, 2. Open Payments lists research payments to Dr. Fischer that name 1 trial.

CMS Open Payments shows 989 general payments to Dr. Fischer from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Abbvie Inc. paid the most, $2,932. It also lists 3 research payments totaling $16,970 from 2023 to 2025, naming 1 clinical trial.

Dr. Fischer graduated from OU College of Medicine in 2009. Dr. Fischer is a member of AAD.

Dr. Fischer is in network with 22 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 16. Check the plan with the practice before a visit.